92 related articles for article (PubMed ID: 24830618)
21. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.
Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL
Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883
[TBL] [Abstract][Full Text] [Related]
22. Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma.
Zhang X; Xu P; Ni W; Fan H; Xu J; Chen Y; Huang W; Lu S; Liang L; Liu J; Chen B; Shi W
Pathol Res Pract; 2016 Mar; 212(3):162-70. PubMed ID: 26804244
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
24. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
[TBL] [Abstract][Full Text] [Related]
25. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
[TBL] [Abstract][Full Text] [Related]
26. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
27. Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma.
Chang R; Wei L; Lu Y; Cui X; Lu C; Liu L; Jiang D; Xiong Y; Wang G; Wan C; Qian H
J Mol Histol; 2015 Feb; 46(1):45-56. PubMed ID: 25311764
[TBL] [Abstract][Full Text] [Related]
28. Chaperonin containing TCP1, subunit 8 (CCT8) is upregulated in hepatocellular carcinoma and promotes HCC proliferation.
Huang X; Wang X; Cheng C; Cai J; He S; Wang H; Liu F; Zhu C; Ding Z; Huang X; Zhang T; Zhang Y
APMIS; 2014 Nov; 122(11):1070-9. PubMed ID: 24862099
[TBL] [Abstract][Full Text] [Related]
29. VGLL3 increases the dependency of cancer cells on de novo nucleotide synthesis through GART expression.
Kawamura T; Takehora Y; Hori N; Takakura Y; Yamaguchi N; Takano H; Yamaguchi N
J Cell Biochem; 2022 Jun; 123(6):1064-1076. PubMed ID: 35434822
[TBL] [Abstract][Full Text] [Related]
30. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
[TBL] [Abstract][Full Text] [Related]
32. Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma.
Xu K; Gao J; Yang X; Yao Y; Liu Q
Oncol Rep; 2013 Jun; 29(6):2211-8. PubMed ID: 23545718
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.
Li XR; Ji F; Ouyang J; Wu W; Qian LY; Yang KY
Eur J Surg Oncol; 2006 Dec; 32(10):1130-4. PubMed ID: 16806792
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.
Zhang Y; Guo X; Xiong L; Kong X; Xu Y; Liu C; Zou L; Li Z; Zhao J; Lin N
FEBS Lett; 2012 Dec; 586(24):4362-70. PubMed ID: 23178713
[TBL] [Abstract][Full Text] [Related]
35. Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin.
Ni W; Chen B; Zhou G; Lu C; Xiao M; Guan C; Zhang Y; He S; Shen A; Ni R
J Cell Biochem; 2013 Sep; 114(9):2120-30. PubMed ID: 23553841
[TBL] [Abstract][Full Text] [Related]
36. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
[TBL] [Abstract][Full Text] [Related]
37. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma.
Yamashita T; Honda M; Takatori H; Nishino R; Minato H; Takamura H; Ohta T; Kaneko S
J Hepatol; 2009 Jan; 50(1):100-10. PubMed ID: 19008011
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
39. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
40. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
